590 related articles for article (PubMed ID: 15446308)
1. Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation.
Young HY; Zucker P; Flavell RA; Jevnikar AM; Singh B
Transplantation; 2004 Aug; 78(4):509-15. PubMed ID: 15446308
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF; Rajotte RV
Transplantation; 1995 Aug; 60(4):368-74. PubMed ID: 7652767
[TBL] [Abstract][Full Text] [Related]
4. Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients.
Prange S; Zucker P; Jevnikar AM; Singh B
Transplantation; 2001 Apr; 71(7):982-5. PubMed ID: 11349735
[TBL] [Abstract][Full Text] [Related]
5. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
6. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
7. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
8. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
[TBL] [Abstract][Full Text] [Related]
9. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
[TBL] [Abstract][Full Text] [Related]
10. Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.
Barbara JA; Turvey SE; Kingsley CI; Spriewald BM; Hara M; Witzke O; Morris PJ; Wood KJ
Transplantation; 2000 Dec; 70(11):1641-9. PubMed ID: 11152227
[TBL] [Abstract][Full Text] [Related]
11. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
[TBL] [Abstract][Full Text] [Related]
12. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
Solomon M; Flodström-Tullberg M; Sarvetnick N
Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
[TBL] [Abstract][Full Text] [Related]
13. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
Rivereau AS; You S; Lalain S; Gouin E; Saï P
Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
[TBL] [Abstract][Full Text] [Related]
14. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
Transplantation; 1997 Dec; 64(11):1525-31. PubMed ID: 9415551
[TBL] [Abstract][Full Text] [Related]
18. Role of donor MHC class III genes in the destruction of transplanted islets in NOD mice.
Jevnikar AM; Prange S; Zucker P; Singh B
Ann N Y Acad Sci; 2002 Apr; 958():175-8. PubMed ID: 12021101
[TBL] [Abstract][Full Text] [Related]
19. Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice.
Okitsu T; Bartlett ST; Hadley GA; Drachenberg CB; Farney AC
Am J Transplant; 2001 Jul; 1(2):138-45. PubMed ID: 12099361
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of galectin-9 in islets prolongs grafts survival via downregulation of Th1 responses.
Chou FC; Kuo CC; Wang YL; Lin MH; Linju Yen B; Chang DM; Sytwu HK
Cell Transplant; 2013; 22(11):2135-45. PubMed ID: 23067523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
